Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients

DNMT3A mutation is known as a recurrent event in acute myelogenous leukemia (AML) patients. However, association between DNMT3A genetic polymorphisms and AML patients' outcomes is unknown. DNMT3A 11 SNPs (rs11695471, rs2289195, rs734693, rs2276598, rs1465825, rs7590760, rs13401241, rs7581217, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Xiao-Qing, Zhang, Dao-Yu, Yan, Han, Yang, Yong-Long, Zhu, Ke-Wei, Chen, Yan-Hong, Li, Xi, Yin, Ji-Ye, Li, Xiao-Lin, Zeng, Hui, Chen, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312402/
https://www.ncbi.nlm.nih.gov/pubmed/27528035
http://dx.doi.org/10.18632/oncotarget.11143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312402/
https://www.ncbi.nlm.nih.gov/pubmed/27528035
http://dx.doi.org/10.18632/oncotarget.11143

Ejemplares similares